Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing.

Archive ouverte

Kuentz, Paul | Saint-Onge, Judith | Duffourd, Yannis | Courcet, Jean-Benoît | Carmignac, Virginie | Jouan, Thibaut | Sorlin, Arthur | Abasq Thomas, Claire | Albuisson, Juliette | Amiel, Jeanne | Amram, Daniel | Arpin, Stéphanie | Attie-Bitach, Tania | Bahi-Buisson, Nadia | Barbarot, Sébastien | Baujat, Genevieve | Bessis, Didier | Boccara, Olivia | Bonniere, Maryse | Boute, Odile | Bursztejn, Anne-Claire | Chiaverini, Christine | Cormier-Daire, Valérie | Coubes, Christine | Delobel, Bruno | Edery, Patrick | El Chehadeh, Salima | Francannet, Christine | Genevieve, David | Goldenberg, Alice | Haye, Damien | Isidor, Bertrand | Jacquemont, Marie-Line | Khau van Kien, Philippe | Lacombe, Didier | Martin, Ludovic | Martinovic, Jelena | Maruani, Annabel | Mathieu-Dramard, Michèle | Mazereeuw-Hautier, Juliette | Michot, Caroline | Mignot, Cyril | Miquel, Juliette | Morice Picard, Fanny | Petit, Florence | Phan, Alice | Rossi, Massimiliano | Touraine, Renaud | Verloes, Alain | Vincent, Marie | Vincent-Delorme, Catherine | Whalen, Sandra | Willems, Marjolaine | Marle, Nathalie | Lehalle, Daphne | Thevenon, Julien | Thauvin-Robinet, Christel | Olivier-Faivre, Laurence | Vabres, Pierre | Riviere, Jean-Baptiste

Edité par CCSD ; Nature Publishing Group -

International audience. Postzygotic activating mutations of PIK3CA cause a wide range of mosaic disorders collectively referred to as PIK3CA-related overgrowth spectrum (PROS). We describe the diagnostic yield and characteristics of PIK3CA sequencing in PROS.METHODS:We performed ultradeep next-generation sequencing (NGS) of PIK3CA in various tissues from 162 patients referred to our clinical laboratory and assessed diagnostic yield by phenotype and tissue tested.RESULTS:We identified disease-causing mutations in 66.7% (108/162) of patients, with mutant allele levels as low as 1%. The diagnostic rate was higher (74%) in syndromic than in isolated cases (35.5%; P = 9.03 × 10-5). We identified 40 different mutations and found strong oncogenic mutations more frequently in patients without brain overgrowth (50.6%) than in those with brain overgrowth (15.2%; P = 0.00055). Mutant allele levels were higher in skin and overgrown tissues than in blood and buccal samples (P = 3.9 × 10-25), regardless of the phenotype.CONCLUSION:Our data demonstrate the value of ultradeep NGS for molecular diagnosis of PROS, highlight its substantial allelic heterogeneity, and confirm that optimal diagnosis requires fresh skin or surgical samples from affected regions. Our findings may be of value in guiding future recommendations for genetic testing in PROS and other mosaic conditions

Consulter en ligne

Suggestions

Du même auteur

Low risk of embryonic and other cancers in PIK3CA ‐related overgrowth spectrum: Impact on screening recommendations

Archive ouverte | Faivre, Laurence | CCSD

International audience. Abstract The PIK3CA ‐related overgrowth spectrum (PROS) encompasses various conditions caused by mosaic activating PIK3CA variants. PIK3CA somatic variants are also involved in various cancer...

10 years of CEMARA database in the AnDDI-Rares network: a unique resource facilitating research and epidemiology in developmental disorders in France

Archive ouverte | Messiaen, Claude | CCSD

International audience. Abstract Background In France, the Ministry of Health has implemented a comprehensive program for rare diseases (RD) that includes an epidemiological program as well as the establishment of e...

Clinical and neuroimaging findings in 33 patients with MCAP syndrome: A survey to evaluate relevant endpoints for future clinical trials

Archive ouverte | Garde, Aurore | CCSD

International audience. Abstract Megalencephaly‐CApillary malformation‐Polymicrogyria (MCAP) syndrome results from somatic mosaic gain‐of‐function variants in PIK3CA . Main features are macrocephaly, somatic overgro...

Chargement des enrichissements...